Bailin, Samuel S. https://orcid.org/0000-0003-4990-1013
Koethe, John R.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K12HL143956)
Article History
Accepted: 5 October 2022
First Online: 23 November 2022
Declarations
:
: S.B. has no competing interests to declare.J.K. has served as a consultant to Gilead Sciences, Merck & Co., ViiV Healthcare, Theratechnologies and Janssen Pharmaceuticals. He has also received research support from Gilead Sciences and Merck & Co.
: This article does not contain any studies with human or animal subjects performed by any of the authors.